Barclays Forecasts Strong Price Appreciation for Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works (NYSE:BBWI) had its price target increased by analysts at Barclays from $28.00 to $34.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s price target indicates a potential downside of 5.35% from the company’s current price.

A number of other research analysts also recently commented on BBWI. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Raymond James dropped their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. BMO Capital Markets reissued an “outperform” rating and set a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Robert W. Baird dropped their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. Finally, The Goldman Sachs Group reduced their price target on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $41.88.

Bath & Body Works Trading Up 2.0 %

Shares of BBWI stock opened at $35.92 on Tuesday. The company has a market capitalization of $7.87 billion, a price-to-earnings ratio of 8.83, a P/E/G ratio of 1.14 and a beta of 1.79. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99. The stock’s fifty day simple moving average is $30.81 and its 200-day simple moving average is $35.65.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. On average, sell-side analysts predict that Bath & Body Works will post 3.18 EPS for the current year.

Insider Buying and Selling at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the business’s stock in a transaction dated Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently bought and sold shares of BBWI. CWM LLC boosted its holdings in Bath & Body Works by 6.6% in the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock valued at $198,000 after purchasing an additional 314 shares during the period. Northwest Bank & Trust Co raised its position in shares of Bath & Body Works by 2.5% during the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after buying an additional 315 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its stake in shares of Bath & Body Works by 1.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after buying an additional 322 shares during the period. TD Private Client Wealth LLC grew its position in Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after buying an additional 331 shares in the last quarter. Finally, Citizens & Northern Corp increased its stake in Bath & Body Works by 1.7% during the second quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock valued at $1,151,000 after acquiring an additional 487 shares during the period. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.